© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Asensus Surgical, Inc. (ASXC) shows an Average True Range (ATR) of 0.02 and an Enterprise Value of 54.68M. Its average trading volume over the past 3 months is N/A, indicating liquidity. These fundamental metrics provide insight into ASXC's underlying financial health and market activity.
| ATR | 0.02 |
| Enterprise Value | 54.68M |
| Avg Vol (3 Months) | - |
| Avg Vol (10 Days) | - |
Asensus Surgical, Inc. (ASXC) technical indicators as of January 22, 2026: the SMA 20 is 8.45%, SMA 50 at 5.9%, and SMA 200 at 21.53%. The RSI 14 value is 63.19, suggesting its current momentum. These technical analysis signals help assess ASXC's price trends and potential future movements.
| SMA 20 | 8.45% |
| SMA 50 | 5.9% |
| SMA 200 | 21.53% |
| RSI 14 | 63.19 |
Asensus Surgical, Inc. (ASXC) stock performance overview as of January 22, 2026: The 52-week high is N/A (currently -12.87% below), and the 52-week low is N/A (currently 105.86% above). Over the past year, ASXC's performance is N/A, compared to the S&P 500's 9.18% change.
| 52-Week High | N/A |
| 52-Week High Chg | -12.87% |
| 52-Week Low | N/A |
| 52-Week Low Chg | +105.86% |
| S&P 500 52-Week Chg | 9.18% |
According to market data, Asensus Surgical, Inc. (ASXC) stock's recent performance metrics show that over the last month, ASXC is 2.66%, with a Year-to-Date (YTD) performance of 9.09%. Over the past year, the stock has seen a N/A change. These figures summarize ASXC's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | N/A | N/A | N/A | N/A | N/A | N/A |
| Low | N/A | N/A | N/A | N/A | N/A | N/A |
| Performance | +24.25% | +2.66% | +40.28% | +19.97% | - | +9.09% |
According to current financial data, ASXC stock's P/E (TTM) ratio is -1.11, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for ASXC, including P/S (11.07), P/B (2.60), and P/FCF (-1.48), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | ASXC | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -1.11 | -1.23 | -26.18 | 32.59 |
| P/S (TTM) | 11.07 | 3.71 | 14.12 | 5.98 |
| P/B (TTM) | 2.6 | 147.82 | 2.04 | 5.86 |
| P/FCF (TTM) | -1.48 | -8.68 | -954.85 | 34.34 |